Ebru

Asst. Prof. Ebru BİLGET GÜVEN


Contact:

Office:  D304
Phone: +90 212 533 65 32 / 1357

e-mail: ebru.bguven@khas.edu.tr, bilget@bilkent.edu.tr


Education:

  bogazici Undergrad: Boğaziçi University – Chemistry (1997)
cukurova Master: Çukurova University – Medicinal Biochemistry (1999)
Supervisor: Prof. Kıymet Aksoy
bilkent PhD:   Bilkent University – Molecular Biology and Genetics (2012)
Supervisor: Prof. Rengül Çetin Atalay

 


Academic Experience:

logo Postdoc Ankara University – Faculty of Pharmacy
Supervisor: Prof. Meral Tunçbilek
bilkent Instructor Bilkent University – Molecular Biology and Genetics (2013-2015)
 kadir has Asst. Prof.
Kadir Has University Dept of Bioinformatics and Genetics (2016 – now)

 


Awards:

Sanovel Pharmaceuticals Inc., Drug Research Award (1st place) received for the article published in J Med Chem (PMID: 2240977) (2012)

Full Scholarship for Ph.D. studies from TÜBİTAK (The Scientific and Technological Research Council ofTurkey) tenable at Bilkent University (2006-2012)


Courses Given:

MBG 105 Principles of Biology (Bilkent)
MBG 110 Introduction to Modern Biology (Bilkent)
MBG 312 Biochemistry II (Bilkent)
CH101 Chemistry
CH103 Chemistry I
CH104 Chemistry II
BIO105 Introduction to Modern Biology
BIO305 Biochemistry I
BIO306 Biochemistry II


Membership:

American Chemical Society – associate member
Boğaziçi University Alumni (BUMED)


Research:

Hepatocellular carcinoma
Cell culture

In cellulo drug screen


Past and Current Projects:

 image description DPT (State Planning Organization of Turkey)
Cancer Drug Technologies, KANILTEK Project. (Assoc.Prof. Rengul Cetin-Atalay’s Lab, coordinator: Prof. Mehmet Öztürk) ($1 500 000). Researcher.
 tubitak TÜBİTAK – 112S030. The assessment of the in vivo antitumor effects of a novel small molecule, Cl-ATTM. (Rengul Cetin-Atalay’s Lab) Researcher.
 tubitak TÜBİTAK – 112S182. Synthesis of the New Nucleoside and Nucleobase Analogues Cytotoxic to Liver Cancer Cells and Determination of their Effects on Protein Kinases. (Prof. Meral Tuncbilek’s Lab). Researcher.

 


Recent Publications:

Tuncbilek M, Kucukdumlu A, Bilget Guven E, Altiparmak D, Cetin-Atalay R. “Synthesis of novel 6-substituted amino-9-(B-d-ribofuranosyl)purine analogs and their bioactivities on human epithelial cancer cells.” Bioorg Med Chem Lett.  2018 Jan 2.     PubMed PMID: 29326016. (2018)

Kucukdumlu A, Tuncbilek M, Bilget Guven E, Cetin-Atalay R. “Synthesis of Some Substituted 6-Phenyl Purine Analogues and Their Biological Evaluation as Cytotoxic Agents.” Acta Chim Slov.  2017 Sep; 64(3):621-632.     PubMed PMID: 28862295. (2017)

Durmaz I, Bilget Guven E, Ersahin T, Ozturk M, Calis I, Cetin-Atalay R. “Liver cancer cells are sensitive to Lanatoside C induced cell death independent of their PTEN status.” Phytomedicine.  2016 Jan 15; 23(1):42-51.     PubMed PMID: 26902406. (2016)

Demir Z, Bilget Guven E, Ozbey S, Kazak C, Atalay RC, Tuncbilek M. “Synthesis of novel substituted purine derivatives and identification of the cell death mechanism.” Eur J Med Chem. 2015 Jan 7;89:701- 20. (contributed equally) PubMed PMID: 25462277. (2015)

Tuncbilek M, Bilget Guven E, Onder T, Cetin Atalay R. “Synthesis of novel 6-(4-substituted piperazine-1- yl)-9-(β-D-ribofuranosyl) purine derivatives, which lead to senescence-induced cell death in liver cancer cells.” J Med Chem. 2012 Apr 12;55(7): 3058-65. PubMed PMID: 22409771. (2012)

Gezici O, Durmaz I, Bilget Guven E, Unal O, Ozgun A, Cetin-Atalay R, and Tuncel D. “Dual functionality of conjugated polymer nanoparticles as an anticancer drug carrier and a fluorescent probe for cell imaging.” RSC Adv., 2013. (2013)

 


Theses Supervised: